Drug recall D-0232-2022
Product
Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx Only, 90 capsules, labelled as (a) Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054; (b) Manufactured By: Actavis Laboratories FL. Inc, Fort Lauderdale FL. 33314 USA, Distributed by Avista Pharma Inc. Parsippany, NJ 07054 USA. NDC 62037-597-90
Reason for recall
Labelling: Incorrect Exp. Date
Lots and codes
Lot # 100023805, Exp. Date 05/2023
Recall details
- Recalling firm
- Teva Pharmaceuticals USA, Parsippany, NJ
- Quantity
- 32316 bottles
- Distribution
- Distributed Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- October 27, 2021
- Terminated
- December 21, 2022
Related products
- Cartia – drug information
- NDC 62037-600 Cartia XT · Diltiazem Hydrochloride 300 mg/1 · Actavis Pharma, Inc.
- NDC 62037-597 Cartia XT · Diltiazem Hydrochloride 120 mg/1 · Actavis Pharma, Inc.
- NDC 62037-598 Cartia XT · Diltiazem Hydrochloride 180 mg/1 · Actavis Pharma, Inc.
- NDC 62037-599 Cartia XT · Diltiazem Hydrochloride 240 mg/1 · Actavis Pharma, Inc.